For the Inventor, By the Inventor

Enter assignee name

Norcross, GA, United States of America

Reddy US Therapeutics, Inc.

USPTO Granted Patents = 19

% Expired Patents = 94.7

Forward Citations = 183

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Sivaram Pillarisetti (17 out of 32 patents)

Uday Saxena (17 out of 26 patents)

Christopher W Alexander (14 out of 21 patents)

4. Manojit Pal (14 out of 17 patents)

5. Richard T Timmer (13 out of 14 patents)

6. Gaddam Om Reddy (12 out of 20 patents)

7. Jangalgar Tirupathy Reddy (11 out of 13 patents)

8. Potlapally Rajender Kumar (11 out of 12 patents)

9. Koteswar Rao Yeleswarapu (11 out of 14 patents)

10. Velagala Venkata Rama Murali Krishna Reddy (10 out of 11 patents)

11. Sesha Sridevi Alluri (9 out of 11 patents)

12. Ish Khanna (2 out of 17 patents)

13. Ram Pillarisetti (2 out of 2 patents)

14. Yeleswarapu Koteswar Rao (2 out of 2 patents)

15. Shianlen Cahoon (2 out of 2 patents)

19 patents: Sort by Forward Citations

1. 8008328 - Methods for the treatment of diabetes-associated dyslipdemia (2011-08-30),

2. 7622486 - Pyridine compounds, process for their preparation and compositions containing them (2009-11-24),

3. 7456288 - Heterocyclic compounds and methods of making and using thereof (2008-11-25),

4. 7335656 - Medical devices employing triazine compounds and compositions thereof (2008-02-26),

5. 7332490 - Methods and compositions of novel triazine compounds (2008-02-19),

6. 7332489 - Methods and compositions of novel triazine compounds (2008-02-19),

7. 7332488 - Methods and compositions of novel triazine compounds (2008-02-19),

8. 7273712 - Methods and compositions for detecting compounds that modulate inflammatory responses (2007-09-25),

9. 7268134 - Medical devices employing triazine compounds and compositions thereof (2007-09-11),

10. 7265114 - Methods and compositions of novel triazine compounds (2007-09-04),

11. 7238692 - Medical devices employing triazine compounds and compositions thereof (2007-07-03),

12. 7173032 - Methods and compositions of novel triazine compounds (2007-02-06),

13. 7169785 - Methods and compositions of novel triazine compounds (2007-01-30),

14. 7169784 - Medical devices employing triazine compounds and compositions thereof (2007-01-30),

15. 7163943 - Methods and compositions of novel triazine compounds (2007-01-16),

Company Overview

Reddy US Therapeutics, Inc., based in Norcross, Georgia, is dedicated to the development and commercialization of innovative therapeutic solutions. The company specializes in advanced pharmaceutical formulations and drug delivery systems, focusing on enhancing the efficacy and safety of treatments across various medical conditions. With a commitment to research and development, Reddy US Therapeutics aims to address unmet medical needs and improve patient outcomes through its cutting-edge technologies and collaborative partnerships in the healthcare sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

19 Patents

#27 in Norcross, GA

#324 in Georgia

#17,138 in US

#32,663 in the World

Norcross, GA, United States of America

Reddy US Therapeutics, Inc.

Forward Citations = 183

34 inventors:

Sivaram Pillarisetti (17 out of 32 patents)

Uday Saxena (17 out of 26 patents)

Christopher W Alexander (14 out of 21 patents)

4. Manojit Pal (14 out of 17 patents)

5. Richard T Timmer (13 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reddy US Therapeutics, Inc.. Retrieved from https://idiyas.com/company/reddy-us-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…